Drug intelligence / Profile preview

Xinfuli Granules

Development stage
Unknown
Lead developer
Fuwai Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Xinfuli Granules (XFLG) is a Traditional Chinese Medicine (TCM) herbal formulation developed for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). In a randomized controlled trial conducted at Fuwai Hospital in Beijing, China, XFLG was evaluated as an adjunct to standard heart failure therapy. The formulation demonstrated significant clinical efficacy by reducing the composite risk of all-cause mortality and heart failure-related hospitalizations. Additionally, XFLG treatment was associated with improvements in left ventricular ejection fraction (LVEF), significant reductions in NT-proBNP levels, and enhanced quality of life, including the alleviation of depressive and anxiety states. It is administered orally and has shown a favorable safety profile comparable to standard care alone.

Other names
XinfuliXinfuli Keli

Beyond the preview

Go deeper on Xinfuli Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinfuli Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call